Results 201 to 210 of about 71,892 (273)

Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells

, 2013
M. Balakrishnan, Stephen R. Yant, Luong Tsai, Christopher O’Sullivan, Rujuta A. Bam, Angela Tsai, Anita Niedziela‐Majka, Kirsten M. Stray, Roman Sakowicz, Tomás̆ Cihlář   +9 more
openalex   +2 more sources

Lack of activity of HIV-1 integrase strand-transfer inhibitors on recombinase activating gene (RAG) activity at clinically relevant concentrations. [PDF]

Microbiol Spectr
Demirdjian S, Duong VN, Byrum JN, Nayak A, McKinney CB, Perry JK, Callebaut C, Rodgers KK, Falkard B, Feng JY.   +9 more
europepmc   +1 more source

A Critical Role of the C-terminal Segment for Allosteric Inhibitor-induced Aberrant Multimerization of HIV-1 Integrase

, 2014
Nikoloz Shkriabai, Venkatasubramanian Dharmarajan, Alison Slaughter, Jacques J. Kessl, Ross C. Larue, Lei Feng, James R. Fuchs, Patrick R. Griffin, Mamuka Kvaratskhelia   +8 more
openalex   +1 more source

Monte Carlo Method Based QSAR Modeling of Coumarin Derivates as Potent HIV‐1 Integrase Inhibitors and Molecular Docking Studies of Selected 4‐phenyl Hydroxycoumarins

, 2014
Jovana B. Veselinović, Aleksandar M. Veselinović, Andrey A. Toropov, Alla P. Toropova, Ivana Damnjanović, Goran M. Nikolić   +5 more
openalex   +1 more source

Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report. [PDF]

Open Forum Infect Dis
van Kampen JJA, van Nood E, Mahmud R, Krullaars Z, Voskamp T, Voskamp M, Nijssen T, Voermans JJC, Charpentier C, Le Hingrat Q, van de Vijver DAMC, Gruters RA, Mesplède T.   +12 more
europepmc   +1 more source

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection. [PDF]

J Infect Dis
Truscello E, Wang S, Young J, Sebastiani G, Walmsley SL, Hull M, Cooper C, Klein MB.   +7 more
europepmc   +1 more source

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV

, 2015
Victor Valcour, Serena Spudich, Napapon Sailasuta, Nittaya Phanuphak, Sukalaya Lerdlum, James L. K. Fletcher, Eugène Kroon, Linda L. Jagodzinski, Isabel Elaine Allen, Collin L. Adams, Peeriya Prueksakaew, Bonnie M. Slike, Joanna Hellmuth, Jerome H. Kim, Jintanat Ananworanich   +14 more
openalex   +2 more sources

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. [PDF]

Viruses
Gouissi Anguechia DH, Bouba Y, Semengue ENJ, Ka'e AC, Takou D, Ambe Chenwi C, Beloumou G, Nka AD, Basseck Wome UR, Santoro MM, Ceccherini-Silberstein F, Chatté A, Montesano C, Cappelli G, Colizzi V, Ndjolo A, Mbanya D, Ndembi N, Perno CF, Fokam J.   +19 more
europepmc   +1 more source

A bibliometric analysis of HIV-1 drug-resistant minority variants from 1999 to 2024. [PDF]

AIDS Res Ther
Yan C, Yu F, Li M, Yang X, Sun R, Liang X, Lao X, Zhang H, Lv W, Hu Y, Lai Y, Ding Y, Zhang F.   +12 more
europepmc   +1 more source

Computational and Population-Based HLA Permissiveness to HIV Drug Resistance-Associated Mutations. [PDF]

Pathogens
Mahmud R, Krullaars Z, van Osch J, Rickett D, Brumme ZL, Hensley KS, Rokx C, Gruters RA, van Kampen JJA, Mesplède T.   +9 more
europepmc   +1 more source